Pfizer-BioNTech’s COVID-19 shot found to be effective in kids under 5

By Nikita Chaurasia  | Date: 2022-08-24

Pfizer-BioNTech’s COVID-19 shot found to be effective in kids under 5

Pfizer Inc. and BioNTech SE reported that its COVID-19 vaccine is 73.2% effective among kids aged between 6 months to 4 years. The development comes two months after the vaccine was rolled out in the United States for this age group.

Moreover, the data showed that the vaccine shots generated an immunological response that was similar to that seen in older age groups.

The study that involved 10 symptomatic COVID-19 cases revealed that the vaccine had an 80.3% effectiveness rate. However, experts warned this was just preliminary data due to a low number of symptomatic cases.

Notably, the latest update involved 13 children who had COVID-19 and were studied seven days after receiving a third dose of the Pfizer-BioNTech Coronavirus vaccine, comparable to 21 cases among those who got a placebo. Most of the cases were caused by the Omicron BA.2 variant, which was highly prevalent in March and April of 2022 when the study was conducted.

Pfizer declared that pediatric trials for an Omicron-adapted vaccine will begin in the fall and that it would work with regulators to determine the data required for approval.

Pfizer and BioNTech also stated that they had filed an application seeking U.S. authorization for a bivalent vaccination targeting the BA.4/BA.5 subvariants of Omicron for children under the age of 12 as well as a booster dose for those 12 & above.

The recent data contains pre-clinical and manufacturing information for their bivalent COVID-19 vaccine that was modified for Omicron BA.4/BA.5 as well as data from research on their bivalent Omicron BA.1-adapted vaccine. Once the FDA grants an emergency use authorization (EUA), Pfizer-BioNTech will be prepared to ship dosages of the Omicron BA.4/BA.5-adapted bivalent boosters.

It is worth noting that Pfizer inked a new USD 3.2 billion worth contract with the U.S. government in June of this year, to provide 105 million doses, which also includes its Omicron-specific COVID-19 vaccines.

Source Credits:

https://www.business-standard.com/article/international/pfizer-s-covid-vaccine-73-2-effective-in-kids-under-5-shows-new-data-122082301085_1.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

Chanel pioneers ¬sustainability-linked bonds for combating climate changes

Chanel pioneers ¬sustainability-linked bonds for combating climate changes

By Nikita Chaurasia

French luxury fashion house well-recognized for its perfumes and tweed suits, Chanel, has reportedly unveiled ­sustainability-linked bonds, or SLBs, to combat climate change two years ago when the firm was in need to borrow money. The investor...

NLP Logix Partners and Databricks team up for Lakehouse Platform

NLP Logix Partners and Databricks team up for Lakehouse Platform

By Nikita Chaurasia

NLP Logix, a well-known predictive modeling and machine learning leader, has recently announced that it has entered into a partnership with Databricks, an American enterprise software company, to drive business value by deploying data and artificial ...

Elliptic Labs inks deal with Xiaomi to offer a proximity detection solution

Elliptic Labs inks deal with Xiaomi to offer a proximity detection solution

By Nikita Chaurasia

Elliptic Labs, a global AI software company, has reportedly entered into a new agreement with Xiaomi, one of the third-largest smartphone manufacturers across the globe. With this agreement, Xiaomi will continue to leverage INNER BEAUTY, the AI Vi...

L&T Technology Services partners with Qualcomm to amplify 5G adoption

L&T Technology Services partners with Qualcomm to amplify 5G adoption

By Nikita Chaurasia

L&T Technology Services Limited has recently announced that it is teaming up with Qualcomm Technologies, Inc., the world’s leading wireless technology innovator. With the latest collaboration, the firm plans to offer end-to-end solutions...

PNAS, Straive partner to deliver end-to-end content production services

PNAS, Straive partner to deliver end-to-end content production services

By Nikita Chaurasia

Renowned U.S.-based nonprofit and non-governmental organization, NAS (National Academy of Sciences), has reportedly collaborated with Straive, one of the leading technology-driven solutions providers for Content, EdTech, and Data. With this acquis...